DK2791675T3 - Måling af autoantistoffer under lav ledeevne-betingelser - Google Patents

Måling af autoantistoffer under lav ledeevne-betingelser Download PDF

Info

Publication number
DK2791675T3
DK2791675T3 DK12820994.7T DK12820994T DK2791675T3 DK 2791675 T3 DK2791675 T3 DK 2791675T3 DK 12820994 T DK12820994 T DK 12820994T DK 2791675 T3 DK2791675 T3 DK 2791675T3
Authority
DK
Denmark
Prior art keywords
autoantibodies
under low
measurement
antibodies under
interest
Prior art date
Application number
DK12820994.7T
Other languages
Danish (da)
English (en)
Inventor
Alfred Weber
Andrea Engelmaier
Hans-Peter Schwarz
Original Assignee
Baxalta GmbH
Baxalta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxalta GmbH, Baxalta Inc filed Critical Baxalta GmbH
Application granted granted Critical
Publication of DK2791675T3 publication Critical patent/DK2791675T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4709Amyloid plaque core protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK12820994.7T 2011-12-13 2012-12-13 Måling af autoantistoffer under lav ledeevne-betingelser DK2791675T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161570211P 2011-12-13 2011-12-13
PCT/US2012/069587 WO2013090636A1 (en) 2011-12-13 2012-12-13 Measurement of autoantibodies at low conductivity conditions with increased sensitivity

Publications (1)

Publication Number Publication Date
DK2791675T3 true DK2791675T3 (da) 2018-07-30

Family

ID=47630506

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12820994.7T DK2791675T3 (da) 2011-12-13 2012-12-13 Måling af autoantistoffer under lav ledeevne-betingelser

Country Status (14)

Country Link
US (1) US9075069B2 (enExample)
EP (1) EP2791675B1 (enExample)
JP (1) JP6333731B2 (enExample)
KR (1) KR20140104479A (enExample)
AR (1) AR089233A1 (enExample)
AU (1) AU2012321074B2 (enExample)
DK (1) DK2791675T3 (enExample)
ES (1) ES2685332T3 (enExample)
HR (1) HRP20181118T1 (enExample)
HU (1) HUE038441T2 (enExample)
PL (1) PL2791675T3 (enExample)
PT (1) PT2791675T (enExample)
TW (1) TW201339578A (enExample)
WO (1) WO2013090636A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013203043B2 (en) 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
EP3022225B1 (en) * 2013-07-19 2021-09-29 Board Of Regents Of the University Of Texas System Transthyretin amyloid-selective and polyreactive catabodies
SI24638A (sl) 2014-02-04 2015-08-31 Univerzitetni kliniÄŤni center Ljubljana Fluorometrična imunska metoda za določanje protiteles proti dvojnoverižni DNA
BR112017002575B1 (pt) * 2014-08-08 2023-11-07 Allegheny Singer Research Institute Método para diagnosticar especificamente lúpus sistêmico eritematoso em um indivíduo
JP6674543B2 (ja) 2015-07-31 2020-04-01 アレゲーニー・シンガー リサーチ インスティチュート 抗体に基づく薬物のコンパニオン診断としての細胞結合補体活性化産物アッセイ
KR20170108203A (ko) 2016-03-16 2017-09-27 주식회사 피플바이오 응집형-형성 폴리펩타이드의 응집형을 검출하는 방법
CN108169303B (zh) * 2017-12-07 2019-08-20 商丘师范学院 基于金属有机框架材料作为信号探针的核酸适配体电化学传感器
WO2020010009A1 (en) * 2018-07-02 2020-01-09 Siemens Healthcare Diagnostics Inc. Direct immunoassay measurement of autoantibodies
JP7268306B2 (ja) * 2018-08-31 2023-05-08 東洋紡株式会社 生体試料中の測定対象物質を免疫学的に測定する方法
JP7356128B2 (ja) * 2019-06-07 2023-10-04 慶應義塾 自己免疫疾患の検出剤となるタンパク質複合体、及びその使用
CN113759107A (zh) * 2021-08-18 2021-12-07 苏州立禾生物医学工程有限公司 生物素标记缓冲液

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4259207A (en) * 1979-09-19 1981-03-31 American Hospital Supply Corporation Suspending medium for immunologic reactions
JPS57182168A (en) * 1981-05-02 1982-11-09 Mitsubishi Chem Ind Ltd Immunochemical reagent
US5183735A (en) * 1989-02-27 1993-02-02 Reaads Medical Products, Inc. Method and diagnostic test kit for detection of anti-dsDNA antibodies
US5194585A (en) * 1989-04-25 1993-03-16 Igen, Inc. Inhibitors of catalytic antibodies
US5981180A (en) 1995-10-11 1999-11-09 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
US5763158A (en) 1997-02-06 1998-06-09 The United States Of America As Represented By The Secretary Of The Army Detection of multiple antigens or antibodies
US6958244B2 (en) * 2002-04-12 2005-10-25 Bruker Biospin Corp. Low-conductivity buffers for magnetic resonance measurements
WO2005027714A2 (en) * 2003-07-12 2005-03-31 Accelr8 Technology Corporation Sensitive and rapid biodetection
EP2522753B1 (en) 2007-08-13 2014-04-02 Baxter International Inc. IVIG modulation of chemokines for treatment of Multiple Sclerosis, Alzheimer's disease, and Parkinson's disease
US8852874B2 (en) 2008-02-29 2014-10-07 Baxter International Inc. Anti-amyloid β activity of intravenous immunoglobulin (IVIG) in vitro
EP2418486B1 (en) * 2009-03-05 2013-11-06 Denka Seiken Co., Ltd. Test reagent kit and its use in a method for measuring an analyte in test sample
TW201040529A (en) * 2009-03-31 2010-11-16 Japan Tobacco Inc Method for detecting antibody against SITH-1 in biological sample
BRPI1012082B1 (pt) 2009-05-27 2022-08-16 Takeda Pharmaceutical Company Limited Método para preparar uma composição de igg concentrada a partir de plasma
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield

Also Published As

Publication number Publication date
HUE038441T2 (hu) 2018-10-29
HRP20181118T1 (hr) 2018-09-21
JP6333731B2 (ja) 2018-05-30
JP2015500502A (ja) 2015-01-05
KR20140104479A (ko) 2014-08-28
ES2685332T3 (es) 2018-10-08
PL2791675T3 (pl) 2018-10-31
EP2791675B1 (en) 2018-04-25
US20130149700A1 (en) 2013-06-13
EP2791675A1 (en) 2014-10-22
WO2013090636A1 (en) 2013-06-20
PT2791675T (pt) 2018-07-27
TW201339578A (zh) 2013-10-01
US9075069B2 (en) 2015-07-07
AR089233A1 (es) 2014-08-06
AU2012321074A1 (en) 2013-06-27
AU2012321074B2 (en) 2015-12-03

Similar Documents

Publication Publication Date Title
DK2791675T3 (da) Måling af autoantistoffer under lav ledeevne-betingelser
WO2012097081A3 (en) Protein detection method
WO2011159537A3 (en) Method and device for analyte detection
WO2012038820A3 (en) Immunochromatography devices, methods and kits
MX377956B (es) Sistemas y métodos para maximización de uso de muestras.
WO2010002911A3 (en) Methods and materials for monitoring myeloma using quantitative mass spetrometry
WO2011109372A8 (en) Ultra-sensitive detection of molecules using dual detection methods
WO2011109364A3 (en) Ultra-sensitive detection of molecules or particles using beads or other capture objects
WO2011022093A3 (en) Methods and devices for detecting the presence of an analyte in a sample
WO2010080710A3 (en) Sample collection and measurement in a single container by back scattering interferometry
EP4524571A3 (en) Assay for jc virus antibodies
WO2010046443A3 (en) Methods for detection and diagnosis of a bone or cartilage disorder
WO2011062407A3 (ko) 분석물질의 검출 방법 및 장치
ATE466108T1 (de) Optoelektronisches detektionssystem
WO2011137388A3 (en) Identification and use of biomarkers for detection and quantification of the level of radiation exposure in a biological sample
WO2012071344A3 (en) Nucleotide-based probes and methods for the detection and quantification of macromolecules and other analytes
EA201370030A1 (ru) Бифункциональный количественный анализ in vitro связывания мишени для обнаружения нейтрализующих антител к антителам-мишеням
WO2010056681A3 (en) Thyroid analyte detection and measurement
WO2009072441A1 (ja) 検出方法および検出キット
SG10201907690TA (en) Device and method for detecting target molecules
WO2012021741A3 (en) Lateral flow assays for non-diagnostic analytes
GB201119585D0 (en) Assay
EA201390561A1 (ru) Аналитическое устройство
WO2012075321A3 (en) Trichomonas vaginalis testing using tv5.8s as a target
WO2014004587A3 (en) Protein detection using fet